Dose Finding Study of TNO155 in Adult Patients With Advanced Solid Tumors
Novartis
Novartis
M.D. Anderson Cancer Center
Kivu Bioscience Inc.
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Genentech, Inc.
AstraZeneca
Boehringer Ingelheim
Fox Chase Cancer Center
Radboud University Medical Center
Memorial Sloan Kettering Cancer Center
Boehringer Ingelheim
National Cancer Institute (NCI)
Providence Health & Services
National Cancer Institute (NCI)
National Cancer Institute (NCI)
AbbVie
National Cancer Institute (NCI)
Eli Lilly and Company
National Cancer Institute (NCI)
Johnson & Johnson Enterprise Innovation Inc.
Royal Marsden NHS Foundation Trust
The Methodist Hospital Research Institute
OncoC4, Inc.
City of Hope Medical Center
Exscientia AI Limited
USWM, LLC (dba US WorldMeds)
Seagen Inc.
Seagen Inc.
KaliVir Immunotherapeutics
Pfizer
Pfizer
Fate Therapeutics
Conjupro Biotherapeutics, Inc.
AstraZeneca
Zumutor Biologics Inc.
H. Lee Moffitt Cancer Center and Research Institute
Pfizer
Arcus Biosciences, Inc.
University of Chicago
IDEAYA Biosciences
Memorial Sloan Kettering Cancer Center
Thomas Jefferson University
Sotio Biotech Inc.
Pfizer
Pfizer
Dana-Farber Cancer Institute
Erasca, Inc.
EMD Serono
EpiBiologics